3-methyl-3,4-epoxybutyl diphosphate has been researched along with pyrophosphate in 1 studies
Studies (3-methyl-3,4-epoxybutyl diphosphate) | Trials (3-methyl-3,4-epoxybutyl diphosphate) | Recent Studies (post-2010) (3-methyl-3,4-epoxybutyl diphosphate) | Studies (pyrophosphate) | Trials (pyrophosphate) | Recent Studies (post-2010) (pyrophosphate) |
---|---|---|---|---|---|
5 | 0 | 0 | 6,743 | 183 | 1,175 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Casetti, R; Colizzi, V; D'Offizi, G; Dieli, F; Malkovsky, M; Mattei, M; Perretta, G; Poccia, F; Taglioni, A | 1 |
1 other study(ies) available for 3-methyl-3,4-epoxybutyl diphosphate and pyrophosphate
Article | Year |
---|---|
Drug-induced expansion and differentiation of V gamma 9V delta 2 T cells in vivo: the role of exogenous IL-2.
Topics: 2,3-Diphosphoglycerate; Animals; Antigens; CD4-CD8 Ratio; Cell Differentiation; Cell Proliferation; Cells, Cultured; Diphosphates; Diphosphonates; Epoxy Compounds; Hemiterpenes; Immunologic Memory; Injections, Intravenous; Injections, Subcutaneous; Interferon-gamma; Interleukin-2; Macaca fascicularis; Organophosphorus Compounds; Pamidronate; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocyte Subsets; Th1 Cells | 2005 |